Status:
COMPLETED
A Pharmacokinetic Evaluation Study in Healthy Volunteers
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Healthy
Phase:
PHASE1
Brief Summary
The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous administration.
Eligibility Criteria
Inclusion
- are nonsmokers or those subjects whom have not smoked within 6 months
- are within 20% of their ideal body weight
- are healthy on the basis of a pre-trial physical examination
Exclusion
- history or suspicion of recent alcohol, barbiturate, amphetamine or narcotic abuse or a positive urine drug test at study screening
- history of cardiac arrhythmias, bronchospastic or cardiovascular disease, diabetes mellitus, thyrotoxicosis, Parkinsonism, or drug allergy
- use of concomitant medication other than hormonal contraceptives and multi-vitamins
- donation of blood in the 60 days preceding the screening visit
- have been diagnosed with HIV, hepatitis B or hepatitis C
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2002
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00210054
Start Date
November 1 2002
End Date
December 1 2002
Last Update
October 12 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.